International Eurasian Academy of Sciences, IEAS

Academician

Qingyu WU

Profile:

Elected Academician of the International Eurasian Academy of Sciences in 1998, Professor Qingyu Wu is a distinguished Chinese cardiovascular surgeon whose research and professional work have focused on the surgical treatment of congenital heart disease, coronary artery disease, valvular heart disease, great-vessel disorders, and the use of left ventricular assist devices. Born in January 1952, he graduated from Guangzhou Zhongshan School of Medicine in 1976 and received his master’s degree in cardiovascular surgery from Peking Union Medical College in 1982. He subsequently undertook visiting appointments at Prince Charles Hospital in Brisbane, Australia. He built his academic and clinical career at Fuwai Hospital, Chinese Academy of Medical Sciences, where he served as Professor and Director of Cardiovascular Surgery and Executive Vice President from 1995 to 2004. In 2004, he joined the First Affiliated Hospital of Tsinghua University, where he established the Heart Centre, served as President from 2006 to 2017, and currently serves as Chief Adviser Expert and Director of the Heart Centre. He is also Vice Chairman of the Tsinghua University Academic Committee. He was the first mainland Chinese member of the American Association for Thoracic Surgery and has held memberships and professional roles in several international cardiothoracic and congenital heart surgery organisations. His honours include the State Council Special Allowance and the Lifetime Achievement Award in Congenital Heart Disease Surgery of China. His professional career has encompassed cardiovascular surgery, clinical innovation, medical education, and the development of cardiac surgery in China.

Back to list page →

Professor Wu’s research and clinical work have centred on the surgical treatment of complex congenital and cardiovascular diseases. He developed an anatomical repair approach for Ebstein’s anomaly that has allowed valve replacement to be avoided in more than 98% of patients in his reported series, and presented this work at the 87th Annual Meeting of the American Association for Thoracic Surgery in 2007. He also established a surgical approach to the total correction of tetralogy of Fallot that was associated with a reduction in operative mortality in his series from approximately 10% to below 0.8%. Since 1990, he has introduced or performed a range of complex procedures in China, including the Ross procedure, double-switch operation, off-pump bidirectional Glenn procedure, pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension, and left ventricular assist device implantation as a bridge to transplantation, as well as arterial switch operations in newborns. He was also involved in early international online broadcasting of coronary artery bypass surgery in China and has performed more than 3,500 operations for severe coronary artery disease. He has published nearly 300 scientific papers and fourteen monographs and received four National Science and Technology Progress Awards (Second Prize) and numerous provincial and ministerial awards. Through sustained clinical research, surgical innovation, international academic exchange, and training of cardiovascular surgeons, Professor Wu has contributed to the development of complex cardiac surgery and the dissemination of advanced surgical techniques in China.